Trials / Unknown
UnknownNCT02798913
Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD
Effects of Prolonged Dual Antiplatelet Therapy With Clopidogrel Plus Acetylsalicylic Acid (ASA) After Percutaneous Lower Extremity Revascularization in Patients With Peripheral Arterial Disease
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the present study was to evaluate the prognostic impact of prolonged dual antiplatelet therapy (DAPT) with acetylsalicylic acid plus clopidogrel on the incidence of major adverse cardiovascular events and major adverse limb events after percutaneous lower extremity revascularization in patients with lower extremity peripheral arterial disease (LE-PAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Short DAPT | acetylsalicylic acid 100 mg/day life-long + clopidogrel 75 mg/day for 3 months |
| DRUG | Long DAPT | acetylsalicylic acid 100 mg/day life-long + clopidogrel 75 mg/day for 12 months |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2020-06-01
- Completion
- 2020-07-01
- First posted
- 2016-06-14
- Last updated
- 2019-02-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02798913. Inclusion in this directory is not an endorsement.